The pharmaceutical and biotechnology industries are currently facing very significant challenges which are resulting on major organizational and operational changes. The trend is for pharmaceutical companies to outsource many of their Research and Development operations to third parties with specific specialities and areas of expertise, in order to focus their own resources on areas where they are in a position to maximize value. A Whitepaper by Mestrelab